The stock's fall snapped a two-day winning streak.

In the last year, many Danaher Corporation ( NYSE:DHR ) insiders sold a substantial stake in the company which may ...

TheFly reported on January 7 that TD Cowen raised its price target on DHR to $270 from $260, maintaining a Buy rating.

Mar Vista U.S. Quality Strategy stated the following regarding Danaher Corporation (NYSE:DHR) in its fourth quarter 2025 ...

Better clarity on tariffs, a revival in demand, and the possibility of more corporate tie-ups could help lift Danaher stock ...

What Changed In Danaher’s Price Target Danaher’s fair value estimate has shifted only slightly, moving from about US$258.09 ...

If you are wondering whether Danaher is reasonably priced or carrying a premium right now, you are in the right place for a ...

Allient Inc. stock analysis: long-term outperformance vs QQQ, secular tailwinds, and margin gains—yet valuation is near highs ...

Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 1.08% on an annualized basis producing an average annual return of 13.82%. Currently, Danaher has a market capitalization of ...

Alphabet, Johnson & Johnson and Danaher Corp. were among the portfolio’s top contributors for the quarter, while Oracle, ...

Below is Validea's guru fundamental report for DANAHER CORP (DHR). Of the 22 guru strategies we follow, DHR rates highest using our Growth Investor model based on the published strategy of Martin ...

Washington, the District Of Columbia-based Danaher Corporation (DHR) designs, manufactures, and markets professional, medical ...